Radiology Key

TNM staging system for prostate cancer Primary tumor(T) TX Primary tumor cannot be assessed T0 No evidence of primary tumor T1 Clinically inapparent tumor neither palpable nor visible by imaging…

Fig. 3.1 Relative surviving fractions of EMT6 and SCCVII cells after 8 Gy given without a break or in 5 fractions at various intervals. Cell survival after continuous 8-Gy irradiation…

Author/study PTV Dose/fraction Fractions BED CHT MST Floyd et al. [21] GTV 5.0 Gy 10 75 Gy No 7 m n = 18 Sultanem et al. [22] GTV 3.0 Gy 20 78…

  Number F/U Age Tonsil BT CS IV T4 N2b Dose PTV1 Dose PTV2 Dose PTV3 CRT (%) SIB OS LCR PFS Sher 163 36 M 56.1 50 45 75…

Reference and year of publication Study design Number of patients IMRT dose/fraction size, Gy Chemotherapy % with resected disease Median progression-free survival time, months Median overall survival time, months Neoadjuvant…

Fig. 8.1 Dosimetric comparison of treatment plans for intensity-modulated radiation therapy (IMRT) vs. 3D-conformal RT vs. traditional RT. Axial dose distributions through the center of the nasopharynx and neck for…

Study Year Ce/Hp 5ySR (%) Morbidity n (%) Hospital mortality n (%) Wei et al. [5] 1998 32/37 24 34(49) 6(9) Triboulet et al. [6] 2001 78/131 24 42(33.1) 10(4.8)…

Fig. 4.1 Delineation of the target volumes using FDG-PET/CT and MRI. An advanced nasopharyngeal carcinoma showing extensive infiltrations to the skull base and the clivus. (a) and (b) The FDG-PET/CT…

Fig. 22.1 Axial CT images of adult and pediatric patient treated with IMRT. Images are at the same scale (orange bar). Since the physical characteristics of the delivery hardware are…

Trial Initial publication year # Pts enrolled Radiation technique Median treatment duration (days) Treatment breaks (%) Median treatment break duration (days) Acute G3+ heme toxicity (%) Acute G3+ derm toxicity…